An overview of the PROSECCA project
Up to half of prostate cancer patients receive radiotherapy as part of their treatment and, although it is effective at destroying cancerous lesions deep within the body, this comes at the cost of damaging healthy, or normal, tissues. With 78% of prostate cancer patients surviving for 10 years or more, limiting life-changing side effects for […]
Professor Bill Nailon, Dr David Noble, Zhuolin Yang, Sarah Elliot, Alasdair Rutherford, Dr Tony Hallam, Dr George Beckett, Professor Duncan McLaren
Edinburgh Cancer Centre; University of Edinburgh; Beatson West of Scotland Cancer Centre
